Abstract. Hypertension is a complex multifactorial disorder that is thought to result from the interaction between genetic background and environmental factors. Although various loci and genes have been implicated in the predisposition to hypertension by genetic linkage analyses and candidate gene association studies, the genes that confer susceptibility to this condition remain to be identified definitively. We have now examined the relation of five candidate gene polymorphisms to blood pressure (BP) and the prevalence of hypertension in an 8-year population-based longitudinal cohort study. The 2267 subjects (1128 women, 1139 men) were aged 40-79 years and were randomly recruited to a population-based prospective cohort study of aging and age-related diseases in Japan. BP was measured after subjects had rested in a sitting position for at least 15 min. Genotypes for the -765G¡C polymorphism of PTGS2 and the 67G¡A (Ala23Thr) polymorphism of CCL11 were determined using a fluorescence-based allele-specific DNA primer assay system, and those of the 1444T¡C (3'-UTR) polymorphism of CRP, the -1131T¡C polymorphism of APOA5 and the 1425G¡A (Val374Ile) polymorphism of PRKCH using melting curve analysis. Longitudinal analysis of the relation between systolic or diastolic BP and the five polymorphisms with a mixed-effect model revealed that the polymorphism of CRP was significantly related to systolic BP in all subjects, that of APOA5 to systolic BP in men, and that of PRKCH to diastolic BP in women. Longitudinal analysis of the relation between the prevalence of hypertension and the five polymorphisms with a generalized estimating equation revealed that the CRP, APOA5 and CCL11 polymorphisms were significantly related to the prevalence of hypertension in men, the PTGS2 polymorphism to its prevalence in all subjects, and the PRKCH polymorphism to its prevalence in all subjects and in women. The APOA5 and PRKCH polymorphisms were thus associated with both BP and the prevalence of hypertension in men and women, respectively. These results suggest that the APOA5 and PRKCH polymorphisms are determinants of BP and the development of hypertension in Japanese men and women, respectively.
Introduction
Hypertension is a complex multifactorial disorder thought to result from the interaction between the genetic background of an individual and various environmental factors (1) . Given that hypertension is a major risk factor for coronary heart disease, stroke and chronic renal failure, its personalized prevention is an important public health goal. One approach to this, and to the selection of the most appropriate treatment for the condition, is to identify the genes that confer susceptibility to it. Although genetic linkage analysis (2) (3) (4) (5) and candidate gene association studies (6) (7) (8) (9) have implicated various loci and genes in the predisposition to hypertension, the genes that confer susceptibility to it remain to be identified definitively. In addition, ethnic divergence of gene polymorphisms, as well as of environmental factors and lifestyle, necessitate the examination of the polymorphisms related to hypertension in each ethnic group.
We have been attempting to identify the genes associated with blood pressure (BP) and the prevalence of hypertension in Japanese women and men recruited to a population-based prospective cohort study with a candidate gene approach. In the present study, we selected five candidate genes that might be expected to contribute to the regulation of BP (Table I) . Although there is no apparent biological link between these genes, we examined the relation of their polymorphisms to systolic and diastolic BP and to the prevalence of hypertension. Among the various polymorphisms previously identified, we selected those that might be expected to affect gene function. We thus examined the relation of these polymorphisms to systolic and diastolic BP and to the prevalence of hypertension in community-dwelling Japanese women and men.
Materials and methods
Study population. The National Institute for Longevity Sciences-Longitudinal Study of Aging (NILS-LSA) is a population-based prospective cohort study of aging and age-related diseases, the details of which have been described previously (10-13). We examined the relation of gene polymorphisms to Measurement of BP. BP was measured with an automatic sphygmomanometer (BP-203RV-II; Colin, Tokyo, Japan) in subjects who had been resting in a sitting position for at least 15 min. The BP of each subject was confirmed by measurement performed with a mercury manometer by a physician according to the guidelines of the American Heart Association (14) . Normal BP was defined as both a systolic BP of <140 mmHg and a diastolic BP of <90 mmHg. Hypertension was defined as a systolic BP of ≥140 mmHg or a diastolic BP of ≥90 mmHg (or both), or as the taking of antihypertensive medication.
Genotyping of polymorphisms.
Genotypes for the PTGS2 and CCL11 polymorphisms were determined with a fluorescencebased allele-specific DNA primer assay system (Toyobo Gene Analysis, Tsuruga, Japan) (15) . Primers and other conditions for genotyping are shown in 30 sec, annealing at 65˚C for 30 sec, and extension at 72˚C for 30 sec, followed by a final extension at 72˚C for 2 min. A mixture (2 μl) of 10 pmol of probe labeled at the 5' end with Texas red and 1/400 diluted SYBR-Green I was added to the PCR products, which were then transferred to a PRISM 7700 instrument (Applied Biosystems, Foster City, CA) for measurement of melting temperature. The program for analytic melting comprised incubation at 95˚C for 30 sec, 40˚C for 1 min, then temperatures increasing to 80˚C over 10 min. The fluorescence signals were detected at excitation and emission wavelengths of 485 and 612 nm, respectively.
Statistical analysis. Age, body mass index and BP were compared in subjects with hypertension to the controls using the unpaired Student's t-test, and the prevalence of smoking was compared in the two groups by the χ 2 test. BP values were analyzed in individuals who were not taking antihypertensive drugs. We examined the effects of the genetic variants of CRP, PTGS2, APOA5, PRKCH and CCL11 on systolic and diastolic BP and on the prevalence of hypertension based on an 8-year longitudinal cohort study. The data for the examination of each subject in the first wave (November 1997 Responses for points close in time are usually more highly correlated with each other than responses for points far apart in time. Special methods of analysis are therefore usually needed to accommodate the correlation structure of the repeated measurements. This autoregressive structure was controlled in the mixed-effect model. Systolic and diastolic BP were thus compared in the two groups (dominant or recessive model) by a mixed-effect model with adjustment for age and sex in all Table I . The five gene polymorphisms examined in the study.
subjects or for age in women or in men. Longitudinal changes in the prevalence of hypertension were compared in the two groups by a generalized estimating equation (17) with adjustment for age and sex in all subjects, or for age in women or in men. Age-related changes in systolic or diastolic BP or in the prevalence of hypertension were estimated by quadratic curve controlling for the observation year during which the subjects attended at least one follow-up examination. Allele frequencies were estimated by the gene-counting method, and the χ 2 test was used to identify significant departure from HardyWeinberg equilibrium. A P-value of <0.05 was considered statistically significant. Statistical analysis was performed with SAS software release 9.13 (SAS Institute, Cary, NC).
Results
The baseline characteristics (first wave) of the 2267 study subjects are shown in Table III . Age, body mass index and systolic and diastolic BP were greater in subjects with hypertension than in the controls in the case of both the men and women. The prevalence of smoking was greater in the controls than in the hypertensive subjects in the case of the men.
The relation of the five polymorphisms to systolic and diastolic BP was analyzed with a mixed-effect model in all subjects, in women, and in men (Table IV) . The 1444T¡C (3'-UTR) polymorphism of CRP was significantly related to systolic BP in all subjects, with the CC genotype reflecting a higher BP. The -1131T¡C polymorphism of APOA5 was significantly related to systolic BP in men, with the CC genotype being associated with a lower BP. The 1425G¡A (Val374Ile) polymorphism of PRKCH was significantly related to diastolic BP in women, with the A allele being associated with a higher BP.
The relation of the five polymorphisms to the prevalence of hypertension was analyzed with a generalized estimating equation for all subjects, for women, and for men ( Table V) . The 1444T¡C (3'-UTR) polymorphism of CRP, the -1131T¡C polymorphism of APOA5, and the 67G¡A (Ala23Thr) polymorphism of CCL11 were associated with the prevalence of hypertension among men in a recessive model. The CC genotype of CRP and the AA genotype of CCL11 were risk factors for hypertension, whereas the CC genotype of APOA5 was protective against this condition. The -765G¡C polymorphism of PTGS2 was associated with the prevalence of hypertension in all subjects, with the variant C allele protecting against this condition. The 1425G¡A (Val374Ile) polymorphism of PRKCH was associated with the prevalence of hypertension among all subjects and women, with the variant A allele representing a risk factor for this condition. The genotype distributions of the five polymorphisms in male and female controls were all in Hardy-Weinberg equilibrium.
Given that the -1131T¡C polymorphism of APOA5 and the 1425G¡A (Val374Ile) polymorphism of PRKCH were associated with both BP and the prevalence of hypertension in men and women, respectively, the relation between systolic or diastolic BP and age was analyzed longitudinally, according to genotypes for APOA5 in men and those for PRKCH in women, with a mixed-effect model (Fig. 1) and the relation between the prevalence of hypertension and age was analyzed longitudinally with a generalized estimating equation (Fig. 2) . Table II . Primers, probes, and other PCR conditions for genotyping.
- 
------------------------------------------------------------------------------------------------------------------------------------------------

PTGS2
-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
--------------------------------------------------------------------------------------------------------------------------------------------------------
CRP
------------------------------------------------------------------------------------------------------------------------------------------------
FITC, fluorescein isothiocyanate. Oligonucleotide sequences are 5'¡3'.
Systolic and diastolic BP and the prevalence of hypertension was lower in men with the CC genotype of APOA5 than in the combined group, 40-80 years of age, of those with the TT or TC genotypes. Systolic and diastolic BP and the prevalence of hypertension was higher in the combined group of women of 40-80 years of age with the GA or AA genotypes of PRKCH than in those with the GG genotype
Discussion
The regulation of BP involves the integration of a variety of biological systems that control the structure and tone of the vasculature, as well as the volume and composition of body fluid. It also involves the adaptation of these systems to constantly changing physiological needs (18) . We have now examined the relation of five candidate gene polymorphisms to systolic and diastolic BP, and the prevalence of hypertension in community-dwelling Japanese women and men. Our results show that the -1131T¡C polymorphism of APOA5 and the 1425G¡A (Val374Ile) polymorphism of PRKCH are associated with both BP and the prevalence of hypertension in men and women, respectively. These observations suggest that APOA5 and PRKCH are, respectively, susceptibility loci for the development of hypertension in Japanese men and women. APOA5 is located approximately 27 kb upstream of the well-characterized APOA1-APOC3-APOA4 gene cluster at chromosome 11q23 (19) . The -1131T¡C polymorphism in the promoter region of human APOA5 was found to be associated with plasma triglyceride levels in populations of various ethnicities, with the C allele being a risk factor for increased triglyceride concentrations (20) (21) (22) (23) . This polymorphism was also associated with high-density lipoprotein (HDL)-cholesterol levels, in addition to triglyceride levels in both Asian and Caucasian populations, with individuals with the C allele exhibiting reduced HDL-cholesterol concentrations (21) (22) (23) . A peroxisome proliferator response element (PPRE) has been identified at a position 328 bp downstream of the -1131T¡C polymorphism in the promoter region of APOA5 (24, 25) . The expression of APOA5 was also found to be increased by fibrates acting through peroxisome proliferator-activated receptor α and the PPRE. These observations suggest that the -1131T¡C polymorphism of APOA5 might influence gene expression and thereby affect the circulating concentrations of triglycerides and HDL-cholesterol. We have now shown that the -1131T¡C polymorphism of APOA5 was significantly related to systolic BP and the prevalence of hypertension in men, with the variant CC genotype being associated with a lower BP and protecting against hypertension. The molecular mechanism responsible for this association remains to be elucidated.
Protein kinase C (PKC) is a serine-threonine kinase that regulates a wide variety of important cellular functions, including proliferation, differentiation, and apoptosis. The η isoform of PKC (PRKCH) is regulated by diacylglycerol and phospholipids, but is insensitive to Ca 2+ (26, 27) . Although its specific substrates remain to be identified, PRKCH has been implicated in the cellular response to oxidative stress. The overexpression of PRKCH in human monocytic cells resulted in the induction of inducible nitric oxide synthase and nitric oxide production in response to the exposure of the cells to endotoxin (28) . Evidence also suggests that PRKCH promotes cell growth through the suppression of cyclin E expression (29) and caspase-3 activity (30), as well as through the activation of the Akt signaling pathway (31) . The 1425G¡A (Val374Ile) polymorphism of PRKCH was shown to be associated with the incidence of cerebral infarction in a Japanese population (32) , with the A allele being a risk factor for this condition. This polymorphism is located within the ATP binding site of PRKCH (27) . The Val374Ile substitution enhances the autophosphorylation and kinase activity of PRKCH induced by cell stimuli, thereby promoting signaling by this enzyme (32) . We have now shown that the 1425G¡A (Val374Ile) polymorphism of PRKCH was significantly related to diastolic BP and the prevalence of hypertension in women, with the variant A allele being associated with a higher BP and a risk factor for hypertension. This association might be attributable to an effect of this polymorphism on vascular inflammation, although the underlying molecular mechanism remains to be elucidated.
Given the multiple comparisons of genotypes with BP or the prevalence of hypertension in the present study, it is not possible to exclude completely potential statistical errors, Table III . Baseline characteristics (first wave, n=2267) of male and female subjects with hypertension and the controls. 
Data for age, body mass index, and BP are represented as the means ± SE. a Subjects not taking antihypertensive medication.
- Table IV . Relation of five polymorphisms to systolic and diastolic BP (mmHg) analyzed with a mixed-effect model (first wave to fourth wave). Table V . Relation of five polymorphisms to the prevalence of hypertension analyzed with a generalized estimating equation (first wave to fourth wave). 
The prevalence of hypertension was compared between two groups (dominant or recessive model) for each polymorphism, with adjustment for age and sex in all subjects or for age in women and in men. P-values <0.05 are shown in bold. ND, not determined.
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such as false positives. It is also possible that one or more of the polymorphisms associated with the BP or the prevalence of hypertension in our study is in linkage disequilibrium with other polymorphisms of the same genes or of nearby genes that are actually responsible for the development of hypertension. Furthermore, the relevance of the identified polymorphisms to gene transcription or to protein structure or function was not determined in the present study.
In conclusion, our results implicate the -1131T¡C polymorphism of APOA5 and the 1425G¡A (Val374Ile) polymorphism of PRKCH in the regulation of BP and the development of hypertension in Japanese men and women, respectively. The determination of genotypes for these polymorphisms may prove to be informative to the assessment of the genetic risk for hypertension. Given that multiple variants, each having a small effect, will likely ultimately be found to be responsible for a large fraction of the genetic component of essential hypertension, identification of additional hypertension susceptibility genes will allow for a more accurate assessment of the genetic risk for this condition. 
